Interferon-mediated control of neuropathogenic Flaviviruses

干扰素介导的神经病性黄病毒的控制

基本信息

  • 批准号:
    10552665
  • 负责人:
  • 金额:
    $ 14.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-12 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

Title: Interferon-Mediated Control of Neuropathogenic Flaviviruses Abstract: The primary research goals of this Mentored Clinical Scientist Research Career Development Award proposal are to study mechanisms by which antiviral interferons suppress neuropathogenic Flaviviruses. Flaviviruses, including Zika virus (ZIKV) and West Nile virus (WNV), can cause severe neurological complications, including brain disruption sequence and encephalitis. These manifestations are the net result of both virus-induced effects and host immune responses. The type I interferon (IFN) response establishes a cellular antiviral state through the induction of hundreds of IFN-stimulated genes (ISGs), many of which have direct antiviral effects. Through a cell-based screen to identify novel antiviral ISGs, the candidate uncovered C19orf66 as a potent inhibitor of multiple RNA viruses, including WNV, ZIKV, and Venezuelan equine encephalitis virus (VEEV). The candidate has shown that C19orf66 is required for an optimal IFN response and targets the viral life cycle at the stage of genome replication. Additionally, C19orf66 is basally expressed in primary human neural progenitor cells (hNPs), a useful model to study Zika virus-host interaction. Here, the candidate proposes to further characterize the mechanism of C19orf66 inhibition of Flaviviruses. A combination of molecular virological, cell biological, and biochemical approaches will be used to study: 1) the precise viral life cycle step inhibited by C19orf66, 2) the contribution of C19orf66 to antiviral immunity in hNP cell culture models and 3) the in vivo relevance in a mouse model of ZIKV infection. This research plan, complemented by a comprehensive career development plan that capitalizes on the candidate’s strong clinical interest in central nervous system infections, will lead to an independent research career laid on the foundation of strong education and sound technical skills. The research component of this award will be conducted in the laboratory of Dr. John Schoggins at UT Southwestern, who has significant expertise in basic virology and innate immunity, with additional oversight by co-mentor, Dr. Beth Levine, an expert in virus-host interactions with a strong history of successful mentorship. Critical to the candidate’s career development are attendance and presentations at professional conferences, regular meetings with her advisory committee, courses in fundamentals of neuroscience and immunology, mentorship and career development, research ethics, and hands-on training in the neuroscience lab of Dr. Genevieve Konopka. In summary, this training plan will satisfy the candidate’s short-term goals to strengthen her neuroscience and immunology fund of knowledge and expand her experience in basic science, providing for her long-term goal of independent research in the innate immune control of neuropathogenic Flaviviruses.
干扰素介导的神经致病性黄病毒控制 摘要: 本指导临床科学家研究职业发展奖提案的主要研究目标 是研究抗病毒干扰素抑制神经致病性黄病毒的机制。黄病毒, 包括寨卡病毒(ZIKV)和西尼罗河病毒(WNV),可导致严重的神经系统并发症,包括 脑损伤序列和脑炎这些表现是病毒引起的两种效应的净结果 和宿主免疫反应。I型干扰素(IFN)应答通过以下途径建立细胞抗病毒状态: 诱导数以百计的干扰素刺激基因(ISG),其中许多具有直接的抗病毒作用。通过 一项基于细胞的筛选,以确定新的抗病毒ISG,候选人发现C19orf66作为一种有效的抑制剂, 多种RNA病毒,包括WNV、ZIKV和委内瑞拉马脑炎病毒(VEEV)。候选 已经表明C19orf66是最佳IFN应答所需的,并且靶向病毒生命周期的阶段, 基因组复制此外,C19orf66在原代人神经祖细胞(hNP)中基本表达, 这是研究寨卡病毒与宿主相互作用的有用模型。在此,候选人提议进一步描述 C19orf66抑制黄病毒的机制。分子病毒学、细胞生物学和 生物化学方法将用于研究:1)C19orf66抑制的病毒生命周期的精确步骤,2) C19orf66对hNP细胞培养模型中抗病毒免疫的贡献和3)小鼠中的体内相关性 ZIKV感染模型。这项研究计划,辅之以全面的职业发展计划, 利用候选人对中枢神经系统感染的强烈临床兴趣,将导致 独立的研究生涯奠定了坚实的教育和健全的技术技能的基础。研究 该奖项的组成部分将在UT西南大学的John Schoggins博士的实验室进行, 在基础病毒学和先天免疫方面具有重要的专业知识,并由共同导师Beth博士进行额外监督 莱文是病毒与宿主相互作用方面的专家,有着成功的指导历史。的关键 候选人的职业发展是出席专业会议和演讲,定期 与她的咨询委员会的会议,神经科学和免疫学基础课程,导师制 和职业发展,研究道德,并在Genevieve博士的神经科学实验室进行实践培训 科诺普卡总之,这个培训计划将满足候选人的短期目标,以加强她 神经科学和免疫学基金的知识,并扩大她在基础科学的经验,为她提供 长期目标是独立研究神经致病性黄病毒的先天免疫控制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Natasha Wyndham Hanners其他文献

Natasha Wyndham Hanners的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Natasha Wyndham Hanners', 18)}}的其他基金

Interferon-mediated control of neuropathogenic Flaviviruses
干扰素介导的神经病性黄病毒的控制
  • 批准号:
    10326786
  • 财政年份:
    2019
  • 资助金额:
    $ 14.88万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 14.88万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 14.88万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 14.88万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 14.88万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 14.88万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 14.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了